Biggest News Aggregation in the World
📰 Iagnostics News

Page 38 - Iagnostics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.

Meticulous Market Research Pvt. Ltd.: In-vitro Diagnostics Market to Reach $130.08 Billion by 2030 - Market Size, Share, Forecasts, & Trends Analysis Report by Meticulous Research®

REDDING, Calif., March 23, 2023 /PRNewswire/ -- According to a new market research report titled, 'In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay [ELISA],
Saudi Arabia South Africa United States South Korea Asia Pacific Europe Ro

3DHISTECH and Epredia Open Pathology Innovation Incubator to Accelerate Advancements in Cancer Diagnostics

Two leading pathology and diagnostics companies, 3DHISTECH of Hungary and Epredia, a member of PHC Group , announce the opening of the Pathology Innovation Incubator in Budapest to develop methods... | March 23, 2023
Argyll And Bute United Kingdom United States Steven Lynum Holdings Corporation Epredia Anatomical Pathology Division

The Covid-19 Pandemic Has Served as a Catalyst for Diagnostic Transformation

The Covid-19 pandemic has transformed the way we think of diagnostics in our daily lives. In a recent webinar, BD Vice President for Diagnostics Nikos Pavlidis spoke with a clinician and an epidemiologist where they shared their perspectives on how testing developments have changed the way we track respiratory illnesses.
Northwestern University United States Michelle Prickett Cindy Prins University Of Florida Diagnostics Nikos Pavlidis

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Perspectum Completes $55M Series C to Improve Metabolic Disease Diagnosis

Perspectum — a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and cancer — recently announced the second close of its $55 million Series C funding round. Its flagship product is a diagnostic tool that assesses and monitors chronic liver disease.
United States United Kingdom Rajarshi Banerjee Lahey Health Massachusetts General Hospital Blue Cross Shield

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science